| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2264
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5759
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-80 |
| filingDate |
1997-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca2407913089a45534aca9bae1c0d28b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6751f5d5461e7c508768f6df881d68d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_636363201a86557388e93e17742314dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_106fd5599bd52c9a30d2e47ea1e99571 |
| publicationDate |
1999-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5972888-A |
| titleOfInvention |
Methods of treating nueropeptide Y-associated conditions |
| abstract |
This invention describes methods of treating conditions associated with an excess of neuropeptide Y which comprises administering an obesity protein. This invention also describes methods of treating conditions associated with an excess of neuropeptide Y which comprises administering an obesity protein in combination with a neuropeptide Y antagonist. This invention demonstrates that the obesity protein acts by reducing the production of neuropeptide Y by the hypothalamus. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004034000-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6710059-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6358991-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2002827-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609695-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6696409-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005107327-A1 |
| priorityDate |
1995-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |